Friday, October 29, 2010: 12:30 PM-3:00 PM
5.1
Reviewing the Evidence for Complementary and Alternative Medicine in Child and Adolescent Psychiatry
Suneeta Monga, M.D., FRCPC
Hospital for Sick Children, Toronto, ON
Abel Ickowicz, M.D., FRCPC
Hospital for Sick Children, Toronto, ON
Susan MacKenzie, M.D.
University of Toronto, Toronto, ON
Behnoosh Dashti, M.D., M.P.H.
Hospital for Sick Children, Toronto, ON
5.3
Iron Stores, ADHD, Severity, and Stimulant Dose
Chadi A. Calarge, M.D.
The University of Iowa Carver College of Medicine, Iowa City, IA
Cristan A. Farmer, M.A.
Ohio State University, Columbus, OH
L. Eugene Arnold, M.D.
Ohio State University, Columbus, OH
5.4
Effectiveness and Duration of Effect of Open Treatment in Adult ADHD Patients Treated with Lisdexamfetamine Dimesylate-LDX
Lenard A. Adler, M.D.
New York University School of Medicine, New York, NY
Lauren Lynch, B.A.
NYU School of Medicine, New York, NY
David M. Shaw, B.A.
NYU School of Medicine, New York, NY
Samantha Wallace, M.A.
HELP/PSI, INC, Bronx, NY
Katherine O'Donnell, M.A.
New York University School of Medicine, New York, NY
Michael Ciranni, M.D., Ph.D.
Adult Community Mental Health Services, San Rafael, CA
Alexis M. Briggie, B.A.
NYU School of Medicine, New York, NY
Stephen V. Faraone, Ph.D.
State University of New York Upstate Medical University, Syracuse, NY
5.5
Measurement and Diagnosis of Adult ADHD: An Analysis of Expanded Symptom Criteria From the Adult ADHD Clinical Diagnostic Scale (ACDS)
Lenard A. Adler, M.D.
New York University School of Medicine, New York, NY
Ronald C. Kessler, Ph.D.
Harvard Medical School, Boston, MA
Jennifer Greif Green, Ph.D.
Harvard Medical School, Boston, MA
Russell Barkley, Ph.D.
Medical University of South Carolina, Mt. Pleasant, SC
Somnath Chatterji, M.D.
World Health Organization, Geneva Switzerland
Stephen V. Faraone, Ph.D.
State University of New York Upstate Medical University, Syracuse, NY
Matthew Finkelman, Ph.D.
Tufts University School of Dental Medicine, Boston, MA
Michael J. Gruber, M.S.
Harvard Medical School, Boston, MA
Mark Jewell, Ph.D.
EPI-Q, Oak Brook, IL
Nancy A. Sampson, B.A.
Harvard Medical School, Boston, MA
David L. Van Brunt, Ph.D.
Lilly Research Laboratories, Indianapolis, IN
David M. Shaw, B.A.
NYU School of Medicine, New York, NY
5.6
Reliability of the ADHD Self Report Scale (ASRS) v1.1 Symptom Checklist to Rate Adolescent ADHD Symptoms
Lenard A. Adler, M.D.
New York University School of Medicine, New York, NY
David M. Shaw, B.A.
NYU School of Medicine, New York, NY
Thomas J. Spencer, M.D.
Massachusetts General Hospital, Boston, MA
Jeffrey H. Newcorn, M.D.
Mount Sinai School of Medicine, New York, NY
Paul Hammerness, M.D.
Massachusetts General Hospital, Cambridge, MA
David J. Sitt, Psy.D.
Baruch College, City University of New York, New York, NY
Jennifer V. Davidow, B.S.
Mount Sinai School of Medicine, New York, NY
Stephen V. Faraone, Ph.D.
State University of New York Upstate Medical University, Syracuse, NY
5.7
Autonomic Nervous System Responding During Emotion Induction and Suppression in Children with ADHD
Erica D. Musser, M.S.
University of Oregon, Oregon Health and Sciences University, Eugene, OR
Joel T. Nigg, Ph.D.
Oregon Health and Science University, Portland, OR
5.8
Predicting ADHD From Informant Ratings: Is the Clinician a Valid Alternative to Teacher?
Sarah O'Neill, Ph.D.
Queens College, City University of New York, Flushing, NY
Khushmand Rajendran, Ph.D.
Queens College, City University of New York, Flushing, NY
David J. Marks, Ph.D.
Mount Sinai School of Medicine, New York, NY
Robyn Schneiderman, B.S.
Queens College, City University of New York, Flushing, NY
Jeffrey M. Halperin, Ph.D.
Queens College, City University of New York, Flushing, NY
5.9
Response Inhibition in Children with and without ADHD After Traumatic Brain Injury
Tisha J. Ornstein, Ph.D.
Ryerson University, Toronto, ON
Jeffrey E. Max, M.D.
University of California, San Diego, San Diego, CA
Russell J. Schachar, M.D., FRCPC
University of Toronto, Toronto, ON
Maureen Dennis, Ph.D.
The Hospital for Sick Children, Toronto, ON
Marcia Barnes, Ph.D.
University of Texas Health Science Center at Houston, Houston, TX
Linda Ewing-Cobbs, Ph.D.
University of Texas, Houston, TX
Harvey Levin, Ph.D.
Baylor College of Medicine, Houston, TX
5.10
Hyperactivity Persists in Male and Female Adults with ADHD and Remains a Highly Discriminative Feature of the Disorder
Ann Polcari, Ph.D., R.N.
McLean Hospital and Northeastern University, Belmont, MA
Nikolaos Fourligas, Ph.D.
Department of Biomedical Engineering, Medford, MA
Carryl P. Navalta, Ph.D.
Children's Hospital Boston and Harvard Medical School, Boston, MA
Martin H. Teicher, M.D., Ph.D.
McLean Hospital, Harvard Medical School, Belmont, MA
5.11
Attention Problems and Use of Special Educational Services Among Children in the U.S. Child Welfare System
Khushmand Rajendran, Ph.D.
Queens College, City University of New York, Flushing, NY
Jeffrey M. Halperin, Ph.D.
Queens College, City University of New York, Flushing, NY
5.13
Training Executive, Attention, and Motor Skills (TEAMS): Palatability and Preliminary Efficacy of a Novel Neurocognitive Intervention for ADHD
Jocelyn T. Curchack, B.A.
The Graduate Center, City University of New York, New York, NY
Anne-Claude Bedard, Ph.D.
Mount Sinai School of Medicine, New York, NY
Carol A. Yoon, B.A.
Queens College, City University of New York, Flushing, NY
David J. Marks, Ph.D.
Mount Sinai School of Medicine, New York, NY
Anil Chacko, Ph.D.
Queens College, City University of New York, Flushing, NY
Maribel Ramon, B.A.
Queens College, City University of New York, Flushing, NY
Dione M. Healey, Ph.D.
University of Otago, Dunedin, Otago
Jeffrey M. Halperin, Ph.D.
Queens College, City University of New York, Flushing, NY
5.14
Establishing a Responder Definition for Weiss Functional Impairment Rating Scale, Parent Version and the Child Illness and Health Profile – Child Edition
Beenish Nafees, M.S.C.
Oxford Outcomes Ltd, Oxford United Kingdom
Paul Hodgkins, Ph.D.
Shire Pharmaceuticals Inc., Wayne, PA
Andrew Lloyd, D. Phil.
Oxford Outcomes Ltd, West Way United Kingdom
Rahul Sasane, Ph.D.
Shire Pharmaceuticals Inc., Wayne, PA
Sarah Hearn, M.S.C.
Oxford Outcomes, Oxford United Kingdom
Margaret D. Weiss, M.D., FRCPC, Ph.D.
British Columbia Children's Hospital, Vancouver, BC
5.15
Characterization of Medication Use and Severity of Condition Among Youth with ADHD in the United States, 2007-2008
Melissa L. Danielson, M.P.H.
Centers for Disease Control and Prevention, Atlanta, GA
Susanna Visser, M.S.
Centers for Disease Control and Prevention, Atlanta, GA
5.16
Influence of Extended-Released Methylphenidate on Parenting Stress in ADHD
Yasong Du, Ph.D.
Shanghai Mental Health Center, Shanghai China
Juan Fan, M.D.
Shang mental health center, Shanghai China
Tong Xu, M.D.
Shanghai Changzheng Hospital, Shanghai China
Zhimin Zhao, M.D.
Shang mental health center, Shanghai China
Yi Zhou, B.S.
Shanghai Changzheng Hospital, Shanghai China
Yun Qian, M.D.
Shang mental health center, Shanghai China
5.17
Cerebellar Functions in Child ADHD Patients
Michal Goetz, M.D.
Charles University in Prague, Prague Czech Republic
Jaroslava Schwabova, M.D.
Charles University in Prague, Prague Czech Republic
Alice Maulisova, Psy.D.
University Hospital Motol, Prague, Prague Czech Republic
Marie Hladikova, M.S.C.
Charles University in Prague, Prague Czech Republic
Eliska Mlynarova
Charles University in Prague, Prague Czech Republic
Alena Zumrova, M.D., Ph.D.
Charles University in Prague, Prague Czech Republic
Petr Heřman
Charles University in Prague, Praha Czech Republic
Vladimir Hort, M.D., Ph.D.
Charles University in Prague, Prague Czech Republic
5.18
Rare Copy Number Variants Identify Risk Genes for Attention Deficit and Hyperactivity
Anath C. Lionel, M.S.C.
University of Toronto and The Hospital for Sick Children, Toronto, ON
Russell J. Schachar, M.D., FRCPC
University of Toronto, Toronto, ON
Jennifer Crosbie, Ph.D.
The Hospital for Sick Children, Toronto, ON
Nicole Barbosa, B.S.
The Hospital for Sick Children, Toronto, ON
Tara Goodale, M.S.C.
The Hospital for Sick Children, Toronto, ON
Bhooma Thiruvahindrapduram
The Hospital for Sick Children, Toronto, ON
John Wei, Ph.D.
The Hospital for Sick Children, Toronto, ON
Jessica Rickaby, B.S.
The Hospital for Sick Children, Toronto, ON
Zhouzhi Wang
The Hospital for Sick Children, Toronto, ON
Paul D. Arnold, M.D., Ph.D.
Hospital for Sick Children, Toronto, ON
Christian R. Marshall, Ph.D.
The Hospital for Sick Children, Toronto, ON
Stephen Scherer, Ph.D.
The Hospital for Sick Children, University of Toronto, Toronto, ON
5.19
Heritability of Response Inhibition in Children
Russell J. Schachar, M.D., FRCPC
University of Toronto, Toronto, ON
Nadine Forget-Dubois, Ph.D.
Université Laval, Quebec, QC
Ginette Dionne, Ph.D.
Université Laval, Quebec, QC
Phillipe Robaey, M.D., Ph.D.
University of Ottawa, OTtawa, ON
Michel Boivin, Ph.D.
Université Laval, Quebec, QC
5.20
Pilot Trial of Neurofeedback for ADHD
Nicholas Lofthouse, Ph.D.
The Ohio State University Medical Center, Columbus, OH
L. Eugene Arnold, M.D.
Ohio State University, Columbus, OH
Sarah Hersch, B.S.
The Ohio State University, Columbus, OH
Elizabeth Hurt, Ph.D.
The Ohio State University, Columbus, OH
Xueliang Pan, Ph.D.
The Ohio State University, Columbus, OH
5.22
Pilot Randomized Controlled Trial and Progress to a Large Randomized Clinical Trial
Martin Holtmann, M.D.
LWL-Hospital for Child and Adolescent Psychiatry, Hamm Germany
Daniel Wachtlin
Interdisciplinary Centre Clinical Trials (IZKS), Mainz/Germany, Mainz Germany
Ute Strehl, Ph.D., Psy.D.
Eberhard-Karls-University, Tübingen/Germany, Tübingen Germany
5.23
Sustained Effects of Lisdexamfetamine Dimesylate Across the Day in Children Aged 6 to 12 Years with ADHD: Symptom Control and Rebound
Frank Lopez, M.D.
Children's Developmental Center, Winter Park, FL
Ann Childress, M.D.
Center for Psychiatry and Behavioral Medicine, Inc., Las Vegas, NV
Ben A. Adeyi, M.S.
Shire Development Inc., Wayne, PA
Bryan Dirks, M.D.
Shire Development Inc., Wayne, PA
Thomas Babcock, D.O., Ph.D.
Shire Development Inc., Wayne, PA
Brian Scheckner, Pharm.D.
Shire Development Inc., Wayne, PA
Robert Lasser, M.D., M.B.A.
Shire Development Inc., Wayne, PA
John Shepski, Pharm.D.
Shire Development Inc., Wayne, PA
Valerie K. Arnold, M.D.
University of Tennessee, Memphis, TN
5.24
Efficacy and Safety of Lisdexamfetamine Dimesylate in Children with ADHD and Recent Use of Methylphenidate
Rakesh Jain, M.D.
Research and Development Clinical Research, Inc, Lake Jackson, TX
Thomas Babcock, D.O., Ph.D.
Shire Development Inc., Wayne, PA
Teodor Burtea, M.D.
Shire Canada Inc., Saint Laurent Canada
Bryan Dirks, M.D.
Shire Development Inc., Wayne, PA
Ben A. Adeyi, M.S.
Shire Development Inc., Wayne, PA
Brian Scheckner, Pharm.D.
Shire Development Inc., Wayne, PA
Robert Lasser, M.D., M.B.A.
Shire Development Inc., Wayne, PA
John Renna, M.S., Pharm.D.
Shire Pharmaceuticals Inc., East Northport, NY
Don Duncan, M.D., FRCPC
British Columbia Interior Health ADHD Clinic, Kelowna, BC
5.25
Cardiac Safety of Clonidine Modified Release Therapy in Children and Adolescents with ADHD
Rakesh Jain, M.D.
Research and Development Clinical Research, Inc, Lake Jackson, TX
Robert L. Findling, M.D.
University Hospitals Case Medical Center, Case Western Reserve University, Cleveland, OH
Scott H. Kollins, Ph.D.
Duke University Medical Center, Durham, NC
Moise Khayrallah, Ph.D.
Addrenex Pharmaceuticals, Inc., Morrisville, NC
5.26
Effects of OROS® Methylphenidate on Handwriting in Children with ADHD
Harriette Lynn Starr, M.D.
Ortho-McNeil Janssen Scientific Affairs, LLC, Titusville, NJ
Robert B. Armstrong, M.D.
Ortho-McNeil Janssen Scientific Affairs, LLC, Titusville, NJ
C.V. Damaraju, Ph.D.
Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Raritan, NJ
Steve Ascher, Ph.D.
Johnson & Johnson Pharmaceutical Research and Development, L.L.C., Titusville, NJ
5.27
Effects of OROS® Methylphenidate on Math Performance in Children with ADHD and Comorbid Math Learning Disability
Harriette Lynn Starr, M.D.
Ortho-McNeil Janssen Scientific Affairs, LLC, Titusville, NJ
Robert B. Armstrong, M.D.
Ortho-McNeil Janssen Scientific Affairs, LLC, Titusville, NJ
C.V. Damaraju, Ph.D.
Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Raritan, NJ
Steve Ascher, Ph.D.
Johnson & Johnson Pharmaceutical Research and Development, L.L.C., Titusville, NJ
5.28
Reliability and Validity of
DSM-IV-Based Disruptive Behavior Disorders Test Battery
Eyup Sabri Ercan, M.D.
Ege University School of Medicine, Izmir Turkey
Elif Ercan, M.S.
, Izmir Turkey
Rasiha Kandulu, M.D.
Ege University Medical Faculty, Izmir Turkey
Erman Uslu, M.D.
Taciser Uysal, M.D.
Ege University School of Medicine, Izmir Turkey
Cahide Aydin, M.D.
Ege University School of Medicine, Izmir Turkey
Ülkü Akyol, M.D.
5.29
The Role of ADHD in Academic Fluency: A Follow-up Study
Shirin Ansari, Ph.D.
Center for Learning and Behavioral Solutions, Inc., Irvine, CA
James M. Swanson, Ph.D.
UCI Child Development Center, Irvine, CA
Gregory L. Koch, Ph.D.
Center for Learning and Behavioral Solutions, Inc., Irvine, CA
Sabrina Schuck, Ph.D.
University of California at Irvine, Irvine, CA
Timothy Wigal, Ph.D.
University of California, Irvine, Irvine, CA
Annamarie Stehli, M.P.H.
University of California at Irvine, Irvine, CA
5.30
Caregiver Impact in Families with Children with ADHD: Investigating the Effect of Psychopharmacological Therapy and “Caregiver Peer” Support
Bruno J. Anthony, Ph.D.
Georgetown University Center for Child and Human Development, Washington, DC
Matthew G. Biel, M.D., M.S.C.
Georgetown University Hospital, Washington, DC
Maria E. de Brito McGee, M.D.
Georgetown University Hospital, Washington, DC
Laura G. Anthony, Ph.D.
Center for Autism Spectrum Disorders, George Washington University Medical Center, Rockville, MD
5.31
Effects of Atomoxetine on the QT Interval, Heart Rate, and Blood Pressure In Healthy CYP2D6 Poor Metabolizers
Charles Beasley, M.D.
Eli Lilly and Company, Indianapolis, IN
Corina Loghin, M.D.
Eli Lilly and Company, Indianapolis, IN
Harry Haber, M.P.H.
i3 Statprobe, Ann Arbor, MI
Prajakti Kothare, Ph.D.
Eli Lilly and Company, Indianapolis, IN
Lynnette S. Kauffman, B.A.
Eli Lilly and Company, Indianapolis, IN
John April III, M.A.
Eli Lilly and Company, Indianapolis, IN
Ling Jin, M.D.
Eli Lilly and Company, Indianapolis, IN
Albert J. Allen, M.D., Ph.D.
Eli Lilly and Company, Indianapolis, IN
Malcolm Mitchell, M.B.B.S.
Eli Lilly and Company, Indianapolis, IN
5.32
Quality of Life and Functioning of ADHD Patients Treated with Atomoxetine Compared to Standard Treatment After 6 and 12 Months
Patrick Berquin, M.D., Ph.D.
Centre Hospitalier Universitaire - Université de Picardie Jules Verne, Amiens France
Rodrigo Escobar, M.D.
Eli Lilly and Company, Madrid Spain
Esther Cardo Jalon, M.D.
Hospital Son Llàtzer, Palma de Mallorca, Balearic island
Marina Danckaerts, M.D., Ph.D.
Katholieke Universiteit, Leuven Belgium
Kanasagabai Puvanendran, F.R.C.P., M.B.B.S.
, Basildon, Essex
Katrien De Bruyckere, M.D.
Eli Lilly and Company, Benelux, Brussels Belgium
Alonso Montoya, M.D.
Eli Lilly and Company, Spain, Alcobendas Spain
Deborah Quail, B.S.
Eli Lilly and Company, UK, Windlesham, Surrey
Joaquin Fuentes, M.D.
Policlinica Gipuzkoa, San Sebastian Spain
5.33
A Novel Statistical Method to Predict From Early Changes in Selected Brown ADD Scale Items Longer-Term Response to Atomoxetine in Pediatric Patients
Linda Wietecha, M.S., R.N.
Lilly USA, LLC, Indianapolis, IN
David W. Williams, M.S.
Lilly USA, LLC, Indianapolis, IN
Thomas E. Brown, Ph.D.
Yale University School of Medicine, Hamden, CT
5.34
Social/Emotional Difficulties and Comorbidities Among Children and Adolescents with ADHD and the Impact on Economic Outcomes and School Attendance
Peter Classi, B.A., M.S.
Eli Lilly and Company, Indianapolis, IN
Denai R. Milton, M.S.
Eli Lilly and Company, Indianapolis, IN
Khaled Sarsour, Ph.D.
Eli Lilly and Company, Indianapolis, IN
Sarah Ward, B.A.
Eli Lilly and Company, Indianapolis, IN
Joseph Johnston, M.D.
Eli Lilly and Company, Indianapolis, IN
5.35
Phosphatidylserine Containing Omega 3 Fatty Acids May Ameliorate ADHD Symptoms in Children: A Double-Blind Placebo-Controlled Trial
Iris Manor, M.D.
Geha Mental Health Center, Petach Tikva Israel
5.36
Response Inhibition and Performance Variability Do Not Differentiate Adolescents with Persisting and Remitting ADHD
Tara McAuley, Ph.D.
The Hospital for Sick Children, Toronto, ON
Jennifer Crosbie, Ph.D.
The Hospital for Sick Children, Toronto, ON
Russell J. Schachar, M.D., FRCPC
University of Toronto, Toronto, ON
5.37
Efficacy and Tolerability of Stimulants in Children with ADHD and Severe Mood Dysregulation
James G. Waxmonsky, M.D.
Florida International University, Miami, FL
Meaghan E. Pariseau, B.A.
State University of New York at Buffalo, Buffalo, NY
Peter J. Belin, B.A.
Center For Children and Families, Miami, FL
Daniel A. Waschbusch, Ph.D.
, FL
Opeoluwa Akinnusi, M.D.
, Williamsville, NY
Gregory A. Fabiano, Ph.D.
State University of New York at Buffalo, Buffalo, NY
Jennifer Haak, M.D.
State University of New York at Buffalo, Buffalo, NY
Jinhee Yu, Ph.D.
State University of New York at Buffalo, Buffalo, NY
William E. Pelham, A.B.P.P., Ph.D.
Florida International University, Miami, FL
5.38
A Novel Group-Based Therapy for Children with ADHD and Severe Mood Dysregulation
James G. Waxmonsky, M.D.
Florida International University, Miami, FL
Meaghan E. Pariseau, B.A.
State University of New York at Buffalo, Buffalo, NY
Peter J. Belin, B.A.
Center For Children and Families, Miami, FL
Daniel A. Waschbusch, Ph.D.
, FL
Opeoluwa Akinnusi, M.D.
, Williamsville, NY
Gregory A. Fabiano, Ph.D.
State University of New York at Buffalo, Buffalo, NY
Jennifer Haak, M.D.
State University of New York at Buffalo, Buffalo, NY
Jinhee Yu, Ph.D.
State University of New York at Buffalo, Buffalo, NY
William E. Pelham, A.B.P.P., Ph.D.
Florida International University, Miami, FL
5.39
Maternal Negativity: Longitudinal Associations with Aggression Among Preschool Children with and without Hyperactivity/Inattention
Anna Zarkas, B.A.
Queens College, City University of New York, Flushing, NY
Sarah O'Neill, Ph.D.
Queens College, City University of New York, Flushing, NY
Khushmand Rajendran, Ph.D.
Queens College, City University of New York, Flushing, NY
Chaya B. Gopin, M.A.
The Graduate Center CUNY, Flushing, NY
David J. Marks, Ph.D.
Mount Sinai School of Medicine, New York, NY
Joanne Broome
Queens College, City University of New York, Flushing, NY
Jeffrey M. Halperin, Ph.D.
Queens College, City University of New York, Flushing, NY
5.40
Correlates of Alcohol Use in Adults with ADHD and Comorbid Alcohol Use Disorders: Exploratory Analysis of a Randomized, Double-Blind, Placebo-Controlled Trial of Atomoxetine
Timothy E. Wilens, M.D.
Massachusetts General Hospital, Boston, MA
Lenard A. Adler, M.D.
New York University School of Medicine, New York, NY
Yoko Tanaka, Ph.D.
Eli Lilly and Company, Indianapolis, IN
Feng Xiao, Ph.D.
i3 Statprobe, Cary, NC
Deborah N. D'Souza, M.B.A., Ph.D.
Eli Lilly and Company, Indianapolis, IN
Stephen W. Gutkin, B.A.
Rete Biomedical Communications Corp., Wyckoff, NJ
Himanshu P. Upadhyaya, M.B.B.S., M.S.
Eli Lilly and Company, Bellaire, TX
5.42
Preliminary Findings on Differential Response of ADHD Symptoms to Cognitive Behavioral Therapy
Jessica Stern, M.D.
University of Colorado, Aurora, CO
Paula Riggs, M.D.
University of Colorado at Denver School of Medicine, Aurora, CO
Sung-joon Min, Ph.D.
University of Colorado at Denver, Aurora, CO
5.43
An Open-Label Pilot Study of Memantine for ADHD
Craig Surman, M.D.
Massachusetts General Hospital, Watertown, MA
Paul Hammerness, M.D.
Massachusetts General Hospital, Cambridge, MA
Carter Petty, M.A.
Massachusetts General Hospital, Boston, MA
Robert L. Doyle, M.D.
Massachusetts General Hospital, Boston, MA
Siena C. Napoleon, B.A.
Massachusetts General Hospital, Cambridge, MA
Nicole Chu, B.A.
Massachusetts General Hospital, Cambridge, MA
Joseph Biederman, M.D.
Massachusetts General Hospital, Boston, MA
5.44
ADHD: Is It Best Understood as a Unitary Disorder?
Leanne Tamm, Ph.D.
Utah Southwestern Medical Center, Dallas, TX
Carroll W. Hughes, A.B.P.P., Ph.D.
University of Texas Southwestern Medical Center at Dallas, Dallas, TX
Lauren C. Smith, M.S.
University of Texas Southwestern Medical Center at Dallas, Dallas, TX
Amanda N. Gray, B.S.
University of Texas Southwestern Medical Center at Dallas, Dallas, TX
Kyle Clayton, M.S.
University of Texas Southwestern Medical Center at Dallas, Dallas, TX
Ira H. Bernstein, Ph.D.
University of Texas Southwestern Medical Center at Dallas, Dallas, TX
5.45
Safety and Efficacy of LY2216684 in an Open-Label Study in Pediatric Patients with ADHD
Ling Jin, M.D.
Eli Lilly and Company, Indianapolis, IN
Wen Xu, Ph.D.
Eli Lilly and Company, Indianapolis, IN
William Kielbasa, Ph.D.
Eli Lilly and Company, Indianapolis, IN
Tonya Quinlan, B.S.
Eli Lilly and Company, Indianapolis, IN
Lynnette S. Kauffman, B.A.
Eli Lilly and Company, Indianapolis, IN
Albert J. Allen, M.D., Ph.D.
Eli Lilly and Company, Indianapolis, IN
5.46
Environmental Exposure to Bisphenol A and Phthalates in Relation to Intelligence, Attention, Behavior, and Learning of Korean Children
Soon-Beom Hong, M.D.
Seoul National University Hospital, Seoul South Korea
Jae-Won Kim, M.D., Ph.D.
Seoul National University Hospital, Seoul South Korea
Yun-Chul Hong, M.D., Ph.D.
Seoul National University College of Medicine, Seoul South Korea
Eun Jin Park, M.D.
Inje University Ilsan Paik Hospital, Goyang South Korea
Min-Sup Shin, Ph.D.
Seoul National University Hospital, Seoul South Korea
Boong-Nyun Kim, M.D., Ph.D.
Seoul National University Hospital, Seoul South Korea
Hee Jeong Yoo, M.D., Ph.D.
Seoul National University Bundang Hospital, Seongnam, Kyeonggi-do South Korea
In Hee Cho, M.D., Ph.D.
Gachon University Hospital, Incheon South Korea
Soo Young Bhang, M.P.H.
Ulsan university hospital, Ulsan South Korea
Doug Hyun Han, DrPH
Chung Ang University, Seoul South Korea
Soo-Churl Cho, M.D., Ph.D.
Seoul National University Hospital, Seoul South Korea
5.47
Temperament Traits in Preschool Oppositional Defiant Disorder
Maria Grazia Melegari, M.D.
Azienda Sanitaria Roma A, Roma Italy
Margherita Innocenzi, M.D.
Azienda sanitaria ASL Roma B, Roma Italy
Nicola Vanacore, M.D.
Istituto Superiore di Sanit, Rome Italy
Renato Donfrancesco, M.D.
Azienda sanitaria ASL Roma A, Roma Italy
Maria Giulia Torrioli, M.D.
Università Cattolica Sacro Cuore di Roma, Roma Italy
5.48
Characterization of Young Children with Irritable Mood and Severe Temper Outbursts
Amy K. Roy, Ph.D.
NYU School of Medicine, NYU Langone Medical Center, New York, NY
Aleta Angelosante, Ph.D.
NYU School of Medicine, NYU Langone Medical Center, New York, NY
Leslie Hulvershorn, M.D., M.S.C.
Indiana University School of Medicine, Indianapolis, IN
Erica L. Dixon, B.A.
NYU School of Medicine, NYU Langone Medical Center, New York, NY
Alice Dodds, B.A.
NYU School of Medicine, NYU Langone Medical Center, New York, NY
Carrie Spindel, Psy.D.
NYU School of Medicine, NYU Langone Medical Center, New York, NY
Ellen Leibenluft, M.D.
National Institute of Mental Health, Bethesda, MD
Rachel Klein, Ph.D.
New York University Child Study Center, New York, NY
5.49
The Effects of Perinatal Depression on Infants' Brain Development, Attachment, and Executive Functioning
Dana M. Serino, B.A.
Columbia University, New York, NY
Dana L. Pagar, M.A.
Columbia University, New York, NY
Tove S. Rosen, M.D.
Columbia University Medical Center, New York, NY
Ravi Bansal, Ph.D.
Columbia College of Physicians and Surgeons and the New York State Psychiatric Institute, New york, NY
Zhenyu Zhou
Columbia University Medical Center
Dongrong Xu, Ph.D.
New York State Psychiatric Institute and the College of Physicians and Surgeons of Columbia University, New York, NY
Bradley Peterson, M.D.
Columbia University, New York, NY
5.51
Telephonic and Televideo Consulation for Primary Care Providers in the State of Arkansas
Juan L. Castro, M.D.
University of Arkansas for Medical Sciences, Little Rock, AR
5.52
Psycho-Social Adaptation and Allergic Disorders in Korean School Children
Hyoungyoon Chang, M.D.
Yonsei University, Seoul South Korea
Yee-Jin Shin, M.D., Ph.D.
Yonsei University, Seoul South Korea
Soo-Jong Hong, M.D., Ph.D.
Asan Medical Center, University of Ulsan College of Medicine, Seoul South Korea
Dong-Ho Song, M.D., Ph.D.
Severance Children's Hospital, Yonsei University College of Medicine, Seoul South Korea
Keun-Ah Cheon, M.D., Ph.D.
Severance Children's Hospital, Yonsei University College of Medicine, Seoul South Korea
Dong-Wha Park, M.D.
Severance Children's Hospital, Yonsei University College of Medicine, Seoul South Korea
Kyungun Jhung, M.D.
Severance Children's Hospital, Yonsei University College of Medicine, Seoul South Korea
JinAh Park, Ph.D.
Namseoul University, Cheonan-city South Korea
5.53
Impact of a Cleft Lip and Palate on the Early Mother-Child Relationship: Posttraumatic Stress Disorder Symptoms and Representations
Josee F.L. Despars, DrPH
University Service of Child and Adolescent Psychiatry, Lausanne Switzerland
Camille Peter
Service Universitaire de Psychiatre de l'Enfant et de l'Adolescent
Ayala Borghini, Ph.D.
Service Universitaire de Psychiatrie de l'Enfant et de l'Adolescent, Lausanne Switzerland
Stephanie Habersaat, M.A.
SUPEA - CHUV, Lausanne Switzerland
Blaise Pierrehumbert, Ph.D.
Service Universitaire de Psychiatrie de l'Enfant et de l'Adolescent, Lausanne Switzerland
François Ansermet, M.D.
Service de Psychiatrie de l'Enfant et de l'Adolescent, Genève Switzerland
Judith Hohfeld, M.D.
Centre Hospitalier Universitaire Vaudois, Lausanne, Vaud
Carole Muller-Nix, M.D.
Service Universitaire de Psychiatrie de l'Enfant et de l'Adolescent, Lausanne Switzerland
5.54
Teaching Community Pediatricians to Assess Adolescent Depression and Suicide Risk with a Standardized Patient Module
Elise M. Fallucco, M.D.
Washington University School of Medicine, Saint Louis, MO
Greg Gale, M.D.
Albert Einstein College of Medicine at Beth Israel Medical Center, New York, NY
Mark D. Hanson, M.D.
University of Toronto, Toronto, ON
John N. Constantino, M.D.
Washington University School of Medicine, Saint Louis, MO
Anne L. Glowinski, M.D., M.P.E.
Washington University School of Medicine, Saint Louis, MO
5.55
Auto-Erythrocyte Sensitization Syndrome (Gardener-Diamond Syndrome) in a 15 Year Old Girl: A Case Report and Review of the Literature
Mohammad Jafferany, M.D.
Psychodermatology Clinic, Saginaw, MI
Farhat Shireen, M.D.
Psychodermatology Clinic, Saginaw, MI
Ali Ibrahim, M.D.
Psychodermatology Clinic, Saginaw, MI
5.56
Primary Care Doctors' Experiences in Providing a Medical Home to Child Psychiatric Patients
Linda Chokroverty, M.D.
Albert Einstein College of Medicine of Yeshiva University, Bronx, NY
Emi Kanamaru, M.D., M.P.H.
Dartmouth-Hitchcock Medical Center, Lebanon, NH
Elisa Chefitz, M.D.
Bronx Children's Psychiatric Center, Bronx, NY
Joseph Youngerman, M.D.
Bronx Children's Psychiatric Center, Bronx, NY
5.57
Adherence Issues Related to Follow-up Recommendations of Pediatric Emergency Department Patients with Mental Health Illness
Jane J. Miles, M.D.
University Of Texas Southwestern Medical Center at Dallas, Dallas, TX
Jane Le Vieux, Ph.D., R.N.
Children's Medical Center Dallas, Dallas, TX
Jodie K. Trello-Rishel, M.D.
University of Texas Southwestern, Colleyville, TX
Urszula Barbara Kelley, M.D.
University of Texas Southwestern Medical Center at Dallas, Plano, TX
Shannon Kelly
University of Texas Southwestern Medical Center at Dallas, Dallas, TX
Taryn Mayes, M.S.
University of Texas Southwestern Medical Center, Flower Mound, TX
Elizabeth J. Koury, M.Ed, LPC
Children's Medical Center Dallas, Dallas, TX
Graham J. Emslie, M.D.
University of Texas Southwestern Medical Center at Dallas, Dallas, TX
5.58
Psychiatric Disorders in Children and Adolescents with Dyskeratosis Congenita: A Link to Telomere Biology?
Sandra Rackley, M.D.
Children's National Medical Center, Washington, DC
Sharon A. Savage, M.D.
National Cancer Institute, Rockville, MD
Guillermo F. Seratti, M.D.
National Human Genome Research Institute, Buenos Aires Argentina
Neelam Giri, M.D.
National Cancer Institute, Rockville, MD
Joseph J. Rasimas, M.D., Ph.D.
Penn State College of Medicine, Hershey, PA
Blanche P. Alter, M.D., M.P.H.
National Cancer Institute, Rockville, MD
Maryland Pao, M.D.
National Institute of Mental Health and National Institutes of Health, Bethesda, MD
5.59
An Emerging Culprit for Conversion or Factitious Disorders: Anti–N-Methyl-D-Aspartate Receptor Encephalitis
Nadine Schwartz, M.D.
Drexel University College of Medicine, Philadelphia, PA
Shivani U. Mehta, M.D.
Drexel University College of Medicine, Philadelphia, PA
5.60
Functional Abdominal Pain in Primary Care: Psychiatric and Somatic Outcomes at One Year
John V. Campo, M.D.
Nationwide Children's Hospital, The Ohio State University, Columbus, OH
Cynthia A. Fontanella, Ph.D.
The Ohio State University, Columbus, OH
Jeffrey Bridge, Ph.D.
The Research Institute at Nationwide Children's Hospital, Columbus, OH
Amanda N. Lucas, M.B.A.
Nationwide Children's Hospital, The Ohio State University, Columbus, OH
Cari Dombrowski, M.S.W.
The Research Institute at Nationwide Children's Hospital, Columbus, OH
Carlo DiLorenzo, M.D.
Nationwide Children's Hospital, The Ohio State University, Columbus, OH
David A. Brent, M.D.
Western Psychiatric Institute and Clinic, University of Pittsburgh Medical Center, Pittsburgh, PA
5.61
The Korean Version of the Pediatirc Symptom Checklist: Psychometric Properties In Elementary School-Aged Children
Un-Sun Chung, M.D., Ph.D.
Kyungpook National University Hospital, Daegu South Korea
Sunghoon Jeong, M.D., Ph.D.
Kyungpook National University Hospital, Deagu South Korea
Jeong-Hyun Park, M.D., Ph.D.
Igonggam Psychiatric Clinic, Busan South Korea
Jungjae Lee, M.D.
Kyungpook National University Hospital, Daegu South Korea
Seungjae Lee, M.D., Ph.D.
Kyungpook National University Hospital, Daegu South Korea
Sungman Jang, M.D., Ph.D.
Kyungpook National University Hospital, Daegu South Korea
Hyodeog Rim
Kyungpook National University Hospital, Daegu South Korea
Jungmin Woo, M.D.
Kyungpook National University Hospital, Daegu South Korea
5.62
Reliability and Validity of the Korean Version of the Trauma Symptom Checklist for Children (TSCC-K)
Un-Sun Chung, M.D., Ph.D.
Kyungpook National University Hospital, Daegu South Korea
Hynuyoung Jo
Kyungpook National University Hospital, Daegu South Korea
Sunghoon Jeong, M.D., Ph.D.
Kyungpook National University Hospital, Deagu South Korea
Jungjae Lee, M.D.
Kyungpook National University Hospital, Daegu South Korea
Hyodeog Rim
Kyungpook National University Hospital, Daegu South Korea
Seungjae Lee, M.D., Ph.D.
Kyungpook National University Hospital, Daegu South Korea
Sungman Jang, M.D., Ph.D.
Kyungpook National University Hospital, Daegu South Korea
Jeong-Hyun Park, M.D., Ph.D.
Igonggam Psychiatric Clinic, Busan South Korea
5.63
Reciprocal Relationships: Child Functioning, Maternal Depression and Respect for Child Autonomy
Michal Steinig, B.A.
Queens College, City University of New York, Flushing, NY
Khushmand Rajendran, Ph.D.
Queens College, City University of New York, Flushing, NY
Sarah O'Neill, Ph.D.
Queens College, City University of New York, Flushing, NY
Chaya B. Gopin, M.A.
The Graduate Center CUNY, Flushing, NY
David J. Marks, Ph.D.
Mount Sinai School of Medicine, New York, NY
Jeffrey M. Halperin, Ph.D.
Queens College, City University of New York, Flushing, NY
5.64
Effects of ADHD on Parenting: Evidence for an Evocative Gene-Environment Correlation
Kelly Mebust, B.S.
University of Vermont College of Medicine, Burlington, VT
David C. Rettew, M.D.
University of Vermont College of Medicine, Burlington, VT
James J. Hudziak, M.D.
Vermont Center For Children, Youth and Families, Burlington, VT
